Most likely, the level of NOTCH activation, modulated by DLK1 and DLK2, may led to opposite effects on the invasive properties of MDA-MB-231 breast cancer cells and tumor cell growth in vitro and in vivo. The gene discussed is DLK2; the disease is breast carcinoma.